Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy

Fig. 2

The in vitro cellular distribution of RhoB-labeled mAb MDR1-NPs and RhoB-labeled unmodified NPs following the incubation of SMMC-7721/gefitinib cells. a Fluorescent images of SMMC-7721/gefitinib cells incubated with RhoB-labeled mAb MDR1-NPs. b Fluorescent images of SMMC-7721/gefitinib cells incubated with RhoB-labeled unmodified-NPs. The scale bar in all figure parts is 100 μm

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us